Yunkang’s Revenue Proportion from Joint Construction Business for Medical Institution Alliances and Special Testing Items Continue to Grow in 2024
HONG KONG, Mar 31, 2025 – (ACN Newswire via SeaPRwire.com) – Yunkang Group Limited (“Yunkang” or the “Group”; Stock Code: 2325), a leading medical operation services provider in China, has announced its annual results for the year ended December 31, 2024 (the “Reporting Period”). During the year, the Group adhered to its overall business philosophy […]